NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jayant S Vaidya
University College London - London / United Kingdom
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 1333860
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jayant S Vaidya's MOST POPULAR ARTICLES
1-)
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A …JS Vaidya, F Wenz, M Bulsara, JS Tobias, DJ Joseph, M Keshtgar, ...The Lancet 383 (9917), 603-613, 20149462014
2-)
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJS Vaidya, DJ Joseph, JS Tobias, M Bulsara, F Wenz, C Saunders, ...The Lancet 376 (9735), 91-102, 20109052010
3-)
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJ Cuzick, I Sestak, JF Forbes, M Dowsett, J Knox, S Cawthorn, ...The Lancet 383 (9922), 1041-1048, 20146332014
4-)
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort studyER Copson, TC Maishman, WJ Tapper, RI Cutress, S Greville-Heygate, ...The lancet oncology 19 (2), 169-180, 20184642018
5-)
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...The Lancet 393 (10191), 2599-2612, 20193122019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept